Guanhao Biotech released its performance for the first three quarters, with a net profit attributable to the parent company of 26.7185 million yuan, a decrease of 4.02%
Guanhao Biotech released its Q3 2025 report, with a revenue of 293 million yuan for the first three quarters, a year-on-year increase of 5.52%. The net profit attributable to the parent company was 26.7185 million yuan, a year-on-year decrease of 4.02%; the net profit excluding non-recurring gains and losses was 25.8206 million yuan, a year-on-year increase of 27.60%. The basic earnings per share were 0.1 yuan
According to the Zhitong Finance APP, Guanhao Biotech (300238.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 293 million yuan, a year-on-year increase of 5.52%. The net profit attributable to shareholders of the listed company was 26.7185 million yuan, a year-on-year decrease of 4.02%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 25.8206 million yuan, a year-on-year increase of 27.60%. The basic earnings per share were 0.1 yuan
